Please assess the completion status of the following clinical trial:

Trial Title: Reduction of Right Ventricular Pacing Using the Feature Ventricular Intrinsic Preference (VIP)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patient has been implanted with dual chamber SJM Victory® device with VIP™ for 1 month (± 2 weeks).~* At the time of pacemaker implant, VIP™ is programmed OFF.~* At the time of enrollment, patient is paced in the RV ≤ 60% of the time.~* Patient is medically stable.~Exclusion Criteria:~* Patient has evidence of complete AV block, such that ventricular pacing would be required as part of the patient's routine management.~* Patient is indicated for AF Suppression.~* Patient has persistent or chronic atrial fibrillation.~* Patient is unable to comply with the follow-up visits due to geographical, psychological, or any other reasons.~* Patient is currently participating in another device research study.~* Patient is younger than 18 years of age.~* Patient is pregnant.~* Patients life expectancy is less than 12 months.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 100 Years
- Healthy Volunteers: f

Study Arms:
- VIP On, Then VIP Off (Type: EXPERIMENTAL): Participants first have VIP programmed On after randomization until 3 months, followed by VIP programmed Off from 3 to 6 months.
- VIP Off, Then VIP On (Type: EXPERIMENTAL): Participants first have VIP programmed Off after randomization until 3 months, followed by VIP programmed On from 3 to 6 months.

Based on this trial design, predict the completion outcome and termination type (if applicable).